Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$571M |
| 2 |
Medtronic
MDT
|
+$429M |
| 3 |
Citigroup
C
|
+$412M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$408M |
| 5 |
Gilead Sciences
GILD
|
+$397M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.47B |
| 2 |
Amazon
AMZN
|
+$1.35B |
| 3 |
Apple
AAPL
|
+$1.14B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 5 |
Bank of America
BAC
|
+$718M |
Sector Composition
| 1 | Technology | 16.46% |
| 2 | Healthcare | 15.78% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Financials | 11.25% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPYU
2051
MAX S&P 500 4x Leveraged ETN
SPYU
$431M
| $3.18M | ﹤0.01% |
67,719
-16,041
| -19% | -$752K |
|
2052
Heron Therapeutics
HRTX
$225M
| $3.17M | ﹤0.01% |
1,591,547
+1,050,280
| +194% | +$2.09M |
|
2053
ATN International
ATNI
$232M
| $3.14M | ﹤0.01% |
97,120
-121,725
| -56% | -$3.94M |
|
2054
W&T Offshore
WTI
$261M
| $3.14M | ﹤0.01% |
1,460,679
-834,022
| -36% | -$1.79M |
|
2055
First Trust Indxx Metaverse ETF
ARVR
$2.51M
| $3.14M | ﹤0.01% |
83,686
+38,129
| +84% | +$1.43M |
|
2056
Milestone Pharmaceuticals
MIST
$163M
| $3.13M | ﹤0.01% |
2,061,522
-85,822
| -4% | -$130K |
|
2057
Wendy's
WEN
$1.78B
| $3.11M | ﹤0.01% |
+177,615
| New | +$3.11M |
|
2058
Schwab US Large-Cap Growth ETF
SCHG
$50.6B
| $3.11M | ﹤0.01% |
+119,464
| New | +$3.11M |
|
2059
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$2.82B
| $3.1M | ﹤0.01% |
123,576
-141,022
| -53% | -$3.54M |
|
2060
Woodside Energy
WDS
$28.7B
| $3.1M | ﹤0.01% |
179,741
-130,583
| -42% | -$2.25M |
|
2061
Design Therapeutics
DSGN
$345M
| $3.1M | ﹤0.01% |
575,550
+270,920
| +89% | +$1.46M |
|
2062
Sumitomo Mitsui Financial
SMFG
$108B
| $3.09M | ﹤0.01% |
244,949
-290,948
| -54% | -$3.67M |
|
2063
Hain Celestial
HAIN
$138M
| $3.09M | ﹤0.01% |
358,085
-398,337
| -53% | -$3.44M |
|
2064
Greif
GEF
$3.47B
| $3.08M | ﹤0.01% |
49,204
-5,156
| -9% | -$323K |
|
|
IQIN
2065
DELISTED
NYLI 500 International ETF
IQIN
| $3.08M | ﹤0.01% |
+87,864
| New | +$3.08M |
|
2066
Vanguard Materials ETF
VAW
$2.84B
| $3.08M | ﹤0.01% |
14,558
+2,166
| +17% | +$458K |
|
2067
Northwest Bancshares
NWBI
$1.84B
| $3.08M | ﹤0.01% |
229,887
-46,029
| -17% | -$616K |
|
2068
UroGen Pharma
URGN
$830M
| $3.07M | ﹤0.01% |
242,066
+167,704
| +226% | +$2.13M |
|
|
DESP
2069
DELISTED
Despegar.com
DESP
| $3.06M | ﹤0.01% |
246,981
-271,672
| -52% | -$3.37M |
|
2070
Lindblad Expeditions
LIND
$711M
| $3.06M | ﹤0.01% |
330,951
+45,838
| +16% | +$424K |
|
2071
Black Diamond Therapeutics
BDTX
$187M
| $3.06M | ﹤0.01% |
703,704
+699,175
| +15,438% | +$3.04M |
|
2072
ARK Innovation ETF
ARKK
$9.75B
| $3.05M | ﹤0.01% |
64,201
-1,192,516
| -95% | -$56.7M |
|
2073
Indivior
INDV
$2.81B
| $3.05M | ﹤0.01% |
312,585
+235,748
| +307% | +$2.3M |
|
|
CGAU
2074
Centerra Gold
CGAU
$1.94B
| $3.05M | ﹤0.01% |
425,456
+233,694
| +122% | +$1.67M |
|
2075
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$2.09B
| $3.05M | ﹤0.01% |
137,380
+127,648
| +1,312% | +$2.83M |
|